Clinical Trials Related to Hypochondroplasia

Related studies linked through entity extraction aliases.

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

Status: ENROLLING_BY_INVITATION
Phase: PHASE2

Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

Status: RECRUITING
Phase: N/A

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

Status: RECRUITING
Phase: PHASE2

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Status: ENROLLING_BY_INVITATION
Phase: PHASE3

An Interventional Study of Infigratinib in Children With Hypochondroplasia

Status: ENROLLING_BY_INVITATION
Phase: PHASE2/PHASE3

Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Prospective Clinical Assessment Study in Children With Hypochondroplasia

Status: RECRUITING
Phase: N/A

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Status: RECRUITING
Phase: N/A

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

Status: RECRUITING
Phase: N/A

C-Type Natriuretic Peptide and Achondroplasia

Status: COMPLETED
Phase: N/A

Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children

Status: COMPLETED
Phase: PHASE2